Biolytic Lab Performance Inc.
Fremont, CA
- UEI
- JGZDJWNN7YV5
- CAGE
- 5DH89
- Primary NAICS
- 334516 Analytical Laboratory Instrument Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 5680 Stewart Ave, Fremont, CA 94538, USA
- Website
- biolytic.com
- Founded
- 1993
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $79,760 |
| FY2025 | $80,000 |
| FY2024 | $62,195 |
| FY2023 | $39,200 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $64,260 | |
| 2 | Uniformed Services University of the Health Sciences | $15,500 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| I D T | Coralville, IA | 325199 All Other Basic Organic Chemical Manufacturing |
| Twist Bioscience Corporation | South San Francisco, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| DNA Script Inc. | Cambridge, MA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Edge Biosystems Inc. | San Jose, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| LGC Biosearch Technologies | Petaluma, CA | 325414 Biological Product (except Diagnostic) Manufacturing |
About the company
Biolytic Lab Performance Inc., a veteran-owned for-profit corporation headquartered in Fremont, California, manufactures DNA oligonucleotide synthesizers and provides preventative and corrective maintenance services on specialized laboratory equipment to federal research agencies as a prime contractor, competing exclusively in full-and-open procurements with no set-aside designations across its recent footprint.
The company's capability portfolio centers on the design, sale, and maintenance of DNA synthesizer instruments — particularly the DR. OLIGO 48 and BLP 3900 models — along with associated chemistry instruments, reagents, and full-service warranty plans. Representative work includes a $72,640 firm fixed-price purchase order from the CDC Pittsburgh awarded in March 2026 for DNA synthesizer maintenance services extending through March 2028; a $114,170 equipment sale of a DR. OLIGO 48 AUTO CHEMISTRY INSTRUMENT to the Uniformed Services University of the Health Sciences in September 2022; a $95,700 purchase order from the CDC Pittsburgh in September 2022 for a DR. OLIGO 48 DNA synthesizer; a $56,160 sole-source maintenance contract from the CDC Pittsburgh awarded in September 2025 for BLP 3900 and DR. OLIGO 48 systems through September 2027; and a $30,000 preventative maintenance order from the Uniformed Services University of the Health Sciences in August 2025 for DR. OLIGO 48 equipment at Bethesda, Maryland.
Customer concentration is heavily skewed toward the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh, which accounts for 14 of 25 awards in the top-customer ranking and $639 thousand of the combined potential value across all thirty awards ($1 million total). The Department of the Navy Office of Naval Research represents the second-largest customer by both award count (five awards) and potential value ($76 thousand). The Uniformed Services University of the Health Sciences follows with two awards ($144 thousand combined potential value). Together, these three customers account for 96% of the combined potential value across the vendor's federal footprint. The company has served nine distinct customer agencies since 2010, but activity remains concentrated in the civilian research space.
Award volume has remained modest and flat — four awards in 2021 and 2022, two in 2024, three in 2025, and one in 2026. Three awards totaling $159 thousand in combined potential value face ultimate completion within the next twenty-four months, exposing the vendor to recompete risk across approximately 10% of its visible pipeline. Biolytic Lab Performance operates exclusively as a prime contractor (100% of awards) with no subcontract footprint in the source data. The company's federal contract work is concentrated in NAICS 541711 (Analytical Laboratory Instrument Manufacturing; 14 awards) and PSC code 2440 (Maint/Repair/Rebuild of Equipment—Instruments and Laboratory Equipment; 15 awards), reflecting its core mission as a specialized equipment manufacturer and service provider for federal laboratory infrastructure.
Quick answers
Is Biolytic Lab Performance Inc. registered in SAM.gov?
Yes. Biolytic Lab Performance Inc.'s SAM.gov registration is active through December 4, 2026.
How much has Biolytic Lab Performance Inc. received in federal contracts?
Federal contracts obligated $80,000 to Biolytic Lab Performance Inc. in fiscal year 2025 and $261,155 in fiscal years 2023 through 2027.
What is Biolytic Lab Performance Inc.'s most recent federal award?
Biolytic Lab Performance Inc.'s most recent federal contract award is DNA synthisizer maintenance (75D30126P20893), from CDC Pittsburgh, on March 25, 2026.
On GovTribe
See Biolytic Lab Performance Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors